IGF2BP2 and cholangiocarcinoma: In this study, we showed that IGF2BP2 displayed the highest expression pattern in CCA cells, and specifically promoted CTNNB1 expression in an m6A-dependent manner, indicating that it may be a key m6A reader in CCA patients.